Collaborating to accelerate the development of safe and effective therapies for neonates
Few drugs have been tested in infants. This leads to considerable uncertainty about the medicines given; some may not be beneficial and the best dose is not known for many.
Lynn HudsonOr read this article in our
Tablet/iPad edition
